Fulcrum Therapeutics, Inc. ( FULC ) Q1 2026 Earnings Call April 27, 2026 8:00 AM EDT
Company Participants
Alexander Sapir - CEO, President & Director
Alan Musso - Chief Financial Officer
Iain Fraser - Senior Vice President of Early Development
Conference Call Participants
Joseph Schwartz - Leerink Partners LLC, Research Division
Anupam Rama - JPMorgan Chase & Co, Research Division
Kristen Kluska - Cantor Fitzgerald & Co., Research Division
Corinne Jenkins - Goldman Sachs Group, Inc., Research Division
James Condulis - Stifel, Nicolaus & Company, Incorporated, Research Division
Matthew Biegler - Oppenheimer & Co. Inc., Research Division
Gregory Renza - Truist Securities, Inc., Research Division
Presentation
Operator
Good morning, and welcome to Fulcrum Therapeutics First Quarter 2026 Financial Results and Business Update Conference Call.…